Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JC.83.2.487PMID 9467562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC).

  1997cited by this paper
• Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations

  1997cited by this paper
• Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain

  1997cited by this paper
• GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF

  1996cited by this paper
• GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.

  1996cited by this paper
• Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype.

  1996cited by this paper
• Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.

  1996cited by this paper
• Functional receptor for GDNF encoded by the c-ret proto-oncogene

  1996cited by this paper
• The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

  1996cited by this paper
• GDNF signalling through the Ret receptor tyrosine kinase

  1996cited by this paper
• Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type IIa: Retrospective French Multicentric Study

  1996cited by this paper
• Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.

  1996cited by this paper
• Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.

  1995cited by this paper
• Primary hyperparathyroidism in multiple endocrine neoplasia type 2A

  1995cited by this paper
• Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families

  1995cited by this paper
• Genetic Testing in the Diagnosis and Management of Multiple Endocrine Neoplasia Type II

  1995cited by this paper
• Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

  1995cited by this paper
• RET activation by germline MEN2A and MEN2B mutations.

  1995cited by this paper
• Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

  1995cited by this paper
• A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.

  1995cited by this paper
• RET mutations in exons 13 and 14 of FMTC patients.

  1995cited by this paper
• Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

  1994cited by this paper
• Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

  1994cited by this paper
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

  1994cited by this paper
• Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

  1994cited by this paper
• Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.

  1994cited by this paper
• Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

  1994influential reference
• RET proto-oncogene mutations in French MEN 2A and FMTC families.

  1994influential reference
• Multiple endocrine neoplasia type 2. Clinical features and screening.

  1994cited by this paper
• Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies.

  1994cited by this paper
• Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up.

  1993cited by this paper
• Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2.

  1993cited by this paper
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

  1993cited by this paper

• Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

  2025cites this paper
• MEN2: surgical precision in the era of precision medicine

  2025cites this paper
• Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.

  2025cites this paper
• MEN-2A in a Pregnant Female during the COVID Pandemic: A Double Whammy?

  2025cites this paper
• Primary Hyperparathyroidism in MEN2 Syndromes.

  2025cites this paper
• Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes

  2024cites this paper
• Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?

  2024cites this paper
• Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single‐center study

  2023cites this paper
• Clinical presentation of MEN 2A in index vs. non-index patients

  2023cites this paper
• Iperparatiroidismo nel contesto della MEN2A: dalla genetica alla gestione clinica

  2023cites this paper
• Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results

  2023influential citation
• Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study

  2023cites this paper
• Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutations

  2022cites this paper
• Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism

  2022cites this paper
• Multiple Endocrine Neoplasia in Childhood: An Update on Diagnosis, Screening, Management and Treatment

  2022cites this paper
• Multiple endocrine neoplasia type 2 (MEN2).

  2021cites this paper
• Multiple Endocrine Neoplasias and Associated Non-endocrine Conditions

  2021cites this paper
• Pheochromocytoma/Paraganglioma, Medullary Thyroid Carcinoma, and Hereditary Endocrine Neoplasia Syndromes

  2021cites this paper
• Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma

  2021cites this paper
• Primary hyperparathyroidism: Disease of diverse genetic, symptomatic, and biochemical phenotypes

  2021cites this paper
• Medullary thyroid cancer and pheochromocytoma in MEN2A: are there parent of origin effects on disease expression?

  2021cites this paper
• Syndromic Medullary Thyroid Cancer: MEN 2A and MEN 2B

  2021cites this paper
• Kidney malformations and Hirschsprung’s disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene

  2021cites this paper
• Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study

  2020cites this paper
• Néoplasie endocrinienne multiple de type 2

  2020cites this paper
• The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer.

  2020cites this paper
• 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A

  2020cites this paper
• Multiple Endocrine Neoplasia-Type 2

  2019cites this paper
• A primer on the genetics of medullary thyroid cancer.

  2019cites this paper
• Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure

  2018cites this paper
• 2-6-2011 Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2018cites this paper
• Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.

  2018cites this paper
• Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.

  2018cites this paper
• Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective

  2018cites this paper
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  2018influential citation
• Multiple Endocrine Neoplasia Type 2A Patient with Metastatic Medullary Thyroid Carcinoma and Unilateral Multicentric Pheochromocytoma: A Case Report and Literature Review

  2018cites this paper
• Multiple Endocrine Neoplasia Type 2

  2018cites this paper
• Multiple Endocrine Neoplasia Syndromes

  2018cites this paper
• Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

  2018cites this paper
• Commentary Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2018cites this paper
• Advances in risk-oriented surgery for multiple endocrine neoplasia type 2.

  2017cites this paper
• Molecular Genetics of MEN2-Related Neuroendocrine Tumours

  2017cites this paper
• Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.

  2017cites this paper
• JSM Head and Neck Cancer Cases and Reviews

  2016cites this paper
• RET Gene Analysis in Patients with Medullary Thyroid Carcinoma.

  2016cites this paper
• Genetic Syndromes Associated with Primary Hyperparathyroidism

  2016cites this paper
• Genetic Evaluation of the Patient with Medullary Thyroid Cancer

  2016cites this paper
• Chapter 31 – Systemic Bone Diseases: Medical and Rehabilitation Intervention

  2016cites this paper
• Surgical Management of Parathyroid and Adrenal Glands in Inherited Medullary Thyroid Carcinoma

  2016cites this paper
• A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma

  2016cites this paper
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  2015influential citation
• The Multiple Endocrine Neoplasia Syndromes

  2015cites this paper
• Molecular profiling in primary hyperparathyroidism

  2015cites this paper
• Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.

  2015cites this paper
• [A Case of Hereditary Medullary Thyroid Cancer (MEN2A/FMTC) Diagnosed at the Time of Recurrence].

  2015cites this paper
• RET Cys 634 Arg mutation confers a more aggressive multiple endocrine neoplasia type 2 A phenotype than Cys 634 Tyr mutation

  2015cites this paper
• Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.

  2015cites this paper
• Molecular-genetic diagnosis of a Bulgarian family with multiple endocrine neoplasia, type IIA

  2015cites this paper
• C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.

  2015cites this paper
• Molecular analysis of the rearranged during transfection proto-oncogene in Moroccan patients with medullary thyroid carcinoma

  2015cites this paper
• Primary Hyperparathyroidism in MEN2 Syndromes.

  2015cites this paper
• Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.

  2015cites this paper
• American Thyroid Association guidelines for the management of medullary thyroid carcinoma

  2015cites this paper
• RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation.

  2015cites this paper
• MSAC's advice does not necessarily reflect the views of all individuals who participated in the MSAC evaluation.

  2014cites this paper
• A newly identified missense mutation in RET codon 666 is associated with the development of medullary thyroid carcinoma.

  2014cites this paper
• Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case

  2014cites this paper
• Characterization of wild-type and mutated RET proto- oncogene associated with familial medullary thyroid cancer.

  2014cites this paper
• Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease—a consensus statement of the European Society of Endocrine Surgeons (ESES)

  2014cites this paper
• Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.

  2014cites this paper
• An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease.

  2014cites this paper
• German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

  2013cites this paper
• Cancer médullaire de la thyroïde (CMT) de l'enfant

  2013cites this paper
• Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe

  2013cites this paper
• Hereditary hyperparathyroidism syndromes.

  2013cites this paper
• Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.

  2013cites this paper
• Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma.

  2013cites this paper
• Pheochromocytoma/paraganglioma: clinical and genetic aspects

  2013influential citation
• AUTHOR COPY ONLY Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma

  2013cites this paper
• Multiple Endocrine Neoplasia Type 2 and Bone

  2013cites this paper
• Медуллярный рак щитовидной железы в составе синдрома МЭН 2Б. Клинический случай

  2013cites this paper
• [Medullary thyroid carcinoma in children].

  2013cites this paper
• Multiple endokrine Neoplasien

  2013cites this paper
• CQ27. What Are the Incidences of Diseases Associated with Hereditary Medullary Carcinoma

  2013cites this paper
• Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.

  2013cites this paper
• High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece

  2012cites this paper
• Hyperparathyroidism in Multiple Endocrine Neoplasia

  2012cites this paper
• MEN 2 syndrome masquerading as MEN 1

  2012cites this paper
• Genetic Aspects of Hereditary Hyperparathyroidism

  2012cites this paper
• Multiple endocrine neoplasia type 2: An overview

  2011cites this paper
• Multiple type 2 endocrine neoplasia (case report)

  2011cites this paper
• [Phenotype of the C634Y mutation in the RET proto-oncogene in MEN2A: report of a family].

  2011cites this paper
• CHAPTER 41 – Multiple Endocrine Neoplasia

  2011cites this paper
• Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma

  2011cites this paper
• Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2011cites this paper
• Fenotipo de la mutacin C634Y del protooncogn RET en el MEN2A: a propsito de una familia

  2011cites this paper
• Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

  2011cites this paper
• Familial Catecholamine-Secreting Tumors - Three Distinct Families with Hereditary Pheochromocytoma

  2011cites this paper
• Primary Hyperparathyroidism as the First Clinical Manifestation of Multiple Endocrine Neoplasia Type 2A in a 5-Year-Old Child

  2011cites this paper
• Medullary Thyroid Carcinoma Associated with RET Mutations Located in Exon 8

  2011cites this paper